To determine whether TRPV4 mediated Ca2+ influx can drive EMT marker induction in this model, breast cancer cells were treated with low concentrations of the selective TRPV4 pharmacological activator GSK1016790A [16]. This evidence concerns the gene TRPV4 and breast cancer.